Lexaria Bioscience Corp.

public$LEXX View Live Feed →

Inc: A1

Total Raised

$113,492

Contracts

Patents

PAC Giving

Government Contracts & Awards

No recent government contracts or awards found.

Proprietary Tech & Patents

No patents found in our USPTO sample (a narrow, keyword-clustered feed of recent grants in strategic tech sectors — not a comprehensive patent database).

Form D Funding

Private Placement

Sep 9, 2026

$113,492Raised

Market Intelligence & News

Yahoo Jun 9, 2026

Lexaria's Animal Study Examining Next-Generation GLP-1 drugs is Underway

Retatrutide and amycretin are being investigated for compatibility with Lexaria's proprietary DehydraTECH™ KELOWNA, BC / ACCESS Newswire / June 9, 2026 / Lexaria Bioscience Corp. (NASDAQ:LEXX) ("Lexaria" or the "Company"), a global innovator ...

Congressional Trades in $LEXX

No disclosed congressional trades found in $LEXX.

Insider Trades (Form 4)

No Form 4 insider trades found for $LEXX.

Key People

William Edward McKechnie

Related Person

Christopher Bunka

Related Person

John Docherty

Related Person

Richard Christopher

Related Person

Michael Shankman

Related Person

Nicholas Baxter

Related Person

ALBERT REESE

Related Person

Bal Bhullar

Related Person

Political Giving

No disclosed PAC contributions found for this entity.

Factual Connections

Connections to other companies, executives, and politicians — sourced from disclosed trades, shared officers/directors, and public filings — are a Pro/Alpha feature.

Upgrade to Pro